NRO Neurones SA

NEURONES: Organic growth up 5.4% in 1st quarter 2020

NEURONES: Organic growth up 5.4% in 1st quarter 2020

PRESS INFORMATION

Heading: 1st quarter 2020 revenues

Nanterre, May 6, 2020 (after the closing of the stock exchange)

Organic growth up 5.4% in 1st quarter 2020

(€ millions)Q1 2019Q1 2020growthof which organic
Revenues128.7135.3+5.1%+5.4%

Achievements

Despite the lockdown in effect since March 17, the Group achieved organic growth of +5.4% in the 1st quarter of 2020 (compared with +4.2% over the same period last year).

The operating profit (*) stood at 9.3% of revenues (compared with 9.5% for the 1st quarter of 2019 excluding exceptional capital gains).

Compared with the 2019 Universal Registration Document ( - Investors), the financial position (net cash of €218.3 million at December 31, 2019) has not changed significantly.

Outlook

Organic growth in the 1st quarter, a significant proportion of recurring managed services contracts, low exposure to affected sectors and a probable acceleration of the digital transformation constitute a favorable context. However, the fall in GDP announced at a minimum of -8% (for France) leads the Group to forecast revenues of approximately €475 million for 2020, with an operating profit of at least 6%.

In view of the current high exogenous uncertainties, this estimate is naturally less precise than those of previous years and may be revised in the light of the behavior of economic agents in the coming quarters, which is difficult to predict.

(*) unaudited and after inclusion of 0.2% expenses related to bonus shares.

About NEURONES

With 5,400 experts, the NEURONES Group specializes in Consulting (Management, Organization and Digital) and IT Services. It supports its clients in their digital transformation projects and in the upgrading of their information systems.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD (deferred settlement) mid-caps

Press Relations:

O'Connection

Floriane Monnier

Tel.: +33 (0)6 32 37 57 28

 



NEURONES

Matthieu Vautier

Tel.: +33 (0)1 41 37 41 37

Investor Relations:

NEURONES

Paul-César Bonnel

Tel.: +33 (0)1 41 37 41 37

Attachment

EN
06/05/2020

Underlying

NRONeurones SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES: 5.1% organic growth in 2025

NEURONES: 5.1% organic growth in 2025 PRESS INFORMATIONHeading: 2025 annual revenues        Nanterre, February 11, 2026 (after trading) 5.1% organic growth in 2025 (being audited, in € millions)20242025Growthof which organic4rd quarter revenues211.3225+ 6.5%+ 6.2%Annual revenues810.4857.2+ 5.8%+ 5.1% Achievements NEURONES closes the financial year with annual revenue of €857.2 million, exceeding its expectations. Growth is driven by digital and data projects (double-digit growth), while AI-related activities confirm a promising upward trend. With its decentralized and responsive structu...

February 11, 2026 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES : + 5,1% de croissance organique en 2025

NEURONES : + 5,1% de croissance organique en 2025 INFORMATION PRESSERubrique : C.A. annuel 2025        Nanterre, le 11 février 2026 (après Bourse) + 5,1% de croissance organique en 2025 (en cours d’audit, en M€)20242025Croissancedont organiqueChiffre d’affaires 4e trimestre211,3225+ 6,5%+ 6,2%Chiffre d’affaires annuel810,4    857,2+ 5,8%+ 5,1% Réalisations NEURONES clôture l’exercice avec un chiffre d’affaires annuel de 857,2 M€, dépassant ainsi ses anticipations. La croissance est portée par les projets digitaux et data (progression à deux chiffres), tandis que les activités liées à l’I...

February 11, 2026 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES: Organic growth up 5.1% in 3rd quarter 2025

NEURONES: Organic growth up 5.1% in 3rd quarter 2025 PRESS INFORMATIONHeading: 3rd quarter 2025 revenues        Nanterre, November 5, 2025 (after trading) Organic growth up 5.1% in 3rd quarter 2025 (not audited, in millions of euros)20242025growthof which organic3rd quarter revenues196.7207.9+ 5.7%+ 5.1%Total as at the end-September599.1632.2+ 5.5%+ 4.7% Achievements In a declining French market, NEURONES has continued its momentum in the third quarter, in line with the start of the year. Growth is particularly strong in the areas of Data & AI, digital projects, ITSM (Ser...

November 5, 2025 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025 INFORMATION PRESSERubrique : C.A. 3e trimestre 2025        Nanterre, le 5 novembre 2025 (après Bourse) + 5,1% de croissance organique au 3e trimestre 2025 (non audités, en millions d’euros)20242025croissancedont organiqueChiffre d’affaires 3e trimestre196,7207,9+ 5,7%+ 5,1%Cumul à fin septembre599,1632,2+ 5,5%+ 4,7% Réalisations Dans un marché français en repli, NEURONES a poursuivi sa dynamique au 3e trimestre, dans la continuité du début de l’année. La croissance est particulièrement soutenue dans les domain...

November 5, 2025 1 EN
 PRESS RELEASE
Free
NRO NEURONES SA

NEURONES: Declaration of transactions on treasury shares (October 13 t...

NEURONES: Declaration of transactions on treasury shares (October 13 to 17, 2025) Nanterre, October 21, 2025 Declaration of transactions on treasury shares(period from 13 to 17 October 2025) As part of the share buyback program authorized by the General Meeting of June 5, 2025, NEURONES made the following purchases between October 13 and 17, 2025 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)10/16/202510,000€38.0510/17/2025      489€38.10Total10,489  As of October 17, 2025, excluding the liquidity contract, NEURONES now holds 10,489 ...

October 21, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch